Tekla Life Sciences Investors (HQL) — Cash Flow Reinvestment Rate
Tekla Life Sciences Investors (HQL) has a Cash Flow Reinvestment Rate of 0.00x as of March 2015, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $45.81K. Check Tekla Life Sciences Investors cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Tekla Life Sciences Investors Cash Flow Reinvestment Rate (2008–2013)
Historical reinvestment intensity for Tekla Life Sciences Investors across 6 annual periods. Explore HQL long-term investments to assets to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Tekla Life Sciences Investors (2008–2013)
Year-by-year capital reinvestment analysis for Tekla Life Sciences Investors. For live market cap and broader valuation context, see Tekla Life Sciences Investors (HQL) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2013 | 0.00x | $0.00 | $9.47K | $0.00 | — |
| 2012 | 0.00x | $0.00 | $21.11 Million | $0.00 | — |
| 2011 | 0.00x | $0.00 | $118.30 Million | $0.00 | — |
| 2010 | 0.00x | $0.00 | $1.90 Million | $0.00 | — |
| 2009 | 0.00x | $0.00 | $13.00 Million | $0.00 | — |
| 2008 | 0.00x | $0.00 | $11.80 Million | $0.00 | — |